Rating History for Immune Design (IMDZ) by RBC Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/22/2019 | Brian Abrahams | Downgrade | Sector Perform (Outperform) |
6.00 (9.00) |
5.82 (5.85) |
0.52% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/22/2019 | Brian Abrahams | Downgrade | Sector Perform (Outperform) |
6.00 (9.00) |
5.82 (5.85) |
0.52% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||